scPharmaceuticals Inc. Short Interest Update
SCPH Stock | USD 3.60 0.19 5.57% |
Under 51% of Scpharmaceuticals' investor base is interested to short. The analysis of overall sentiment of trading Scpharmaceuticals stock suggests that many investors are impartial at this time. Scpharmaceuticals' investing sentiment shows overall attitude of investors towards Scpharmaceuticals.
Scpharmaceuticals |
scPharmaceuticals Inc. saw a significant decrease in short interest in September. As of September 15th, there was short interest totalling 4,250,000 shares, a decrease of 15.0 percent from the August 31st total of 5,000,000 shares. Based on an average daily volume of 264,000 shares, the short-interest ratio is currently 16.1 days.
Read at thelincolnianonline.com
Scpharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Scpharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Scpharmaceuticals Fundamental Analysis
We analyze Scpharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scpharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scpharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Scpharmaceuticals is currently under evaluation in target price category among its peers.
Scpharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scpharmaceuticals stock to make a market-neutral strategy. Peer analysis of Scpharmaceuticals could also be used in its relative valuation, which is a method of valuing Scpharmaceuticals by comparing valuation metrics with similar companies.
Peers
Scpharmaceuticals Related Equities
CTMX | CytomX Therapeutics | 6.25 | ||||
ASMB | Assembly Biosciences | 2.63 | ||||
SLNO | Soleno Therapeutics | 1.96 | ||||
CAPR | Capricor Therapeutics | 1.28 | ||||
CRNX | Crinetics Pharmaceuticals | 1.21 | ||||
ACHL | Achilles Therapeutics | 0.94 | ||||
MBRX | Moleculin Biotech | 1.13 | ||||
BPTH | Bio Path | 2.44 | ||||
TIL | Instil Bio | 2.83 |
Complementary Tools for Scpharmaceuticals Stock analysis
When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Stocks Directory Find actively traded stocks across global markets | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |